Oliver is a member of the Cancer Systems Biology group (Miller Laboratory), analysing how chemotherapy changes the immune system of cells. Through recognising the methods cancer uses to exploit the immune system, new treatments may be developed.
Oliver’s contribution is acknowledged in an article about the group’s work, published in Nature Genetics.
Read more about the background to Oliver’s research and the difference his Harding Distinguished Postgraduate Scholarship has made.